|Bid||2.1300 x 3200|
|Ask||2.1400 x 1400|
|Day's Range||2.1250 - 2.2400|
|52 Week Range||1.3200 - 4.6500|
|Beta (3Y Monthly)||1.91|
|PE Ratio (TTM)||4.33|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
(Bloomberg) -- GNC Holdings Inc. is exploring options to rework its nearly $900 million debt load to get ahead of key borrowing dates, according to people with knowledge of the situation.The health and wellness company is in talks with creditors about ways to bolster its capital structure before maturities come due, the people said, asking not to be identified discussing confidential matters. GNC’s $159 million of convertible notes mature in August 2020, with $448 million of term loans due the following year.GNC is working with investment bankers at UBS Group AG, which advised the company on a recent non-deal roadshow, and restructuring advisers at Evercore Inc., the people said.Representatives for the Pittsburgh-based retailer didn’t respond to repeated calls and messages seeking comment. The advisory firms declined to comment.GNC sells health and nutrition products worldwide, including vitamins, supplements, minerals, herbs, sports nutrition, diet and energy supplements. It has over 4,800 retail locations throughout the U.S., including more than 1,000 franchise and 1,200 Rite Aid store-within-a-store locations, as well as franchise operations in 46 international markets, according to its website.GNC plans to shutter as many as 900 stores by the end of next year and is cutting its mall outlets in half as traffic continues to fall, Chief Executive Officer Ken Martindale told investors on a July 22 conference call. While the company is looking at strategies to attract shoppers, the best solution GNC has found is moving out of malls as leases run out, Martindale said. Currently, mall locations make up 28% of GNC’s stores, he said.The chain ran into financial trouble once before, but GNC secured new capital in early 2018 from Harbin Pharmaceutical Group Co., a Chinese sponsor, and expanded its global presence. The company has focused on de-leveraging and reduced its debt by 40% over six quarters, according to a recent investor presentation.The latest effort to rework GNC’s debt load is still in the early stages, the people said. The company has reached out to existing creditors and outside parties about options that could include partial or full pay-down of the convertible notes, the people said, while some lenders prefer a pay-down and potential extension of the term loan.Lender AdvisersA group of lenders, including Franklin Templeton Investments, LibreMax Capital, LLC, Serengeti Asset Management LP and Apollo Global Management Inc., is being advised by restructuring lawyers at Milbank LLP, the people said. The group, which holds more than 75% of the outstanding term loan and more than half of the FILO, heard pitches from investment banks and is hiring Houlihan Lokey Inc. as financial adviser, according to the people.The lenders and advisory firms declined to comment, or didn’t respond to messages.GNC’s term loan due 2021 trades around 95 cents on the dollar, according to data compiled by Bloomberg. Its 2020 convertible notes trade around 93 cents.Harbin invested $300 million in GNC in the form of convertible preferred shares. GNC received the final tranche of the investment in the first quarter of this year. Harbin’s partnership also provided GNC with access to pharmaceutical distribution and manufacturing networks in China, potentially a $25 billion market, which has been a focus of growth for the company.Springing LoanThe restructuring task is complicated by a springing maturity on GNC’s term loan -- an obligation to repay the entire sum next May if $50 million of its convertible bonds are still outstanding.At last count, $159 million of convertibles were still circulating in July, Chief Financial Officer Tricia Tolivar said during the conference call. That’s after buying back about $30 million face value at a $5 million discount, but there’s more than $90 million of cash and $81 million in its revolver available to further reduce the total, Tolivar said.Lenders have pushed back on that idea, the people said, because they want some cash to be left to chip away at the loan balance.To contact the reporter on this story: Katherine Doherty in New York at firstname.lastname@example.orgTo contact the editors responsible for this story: Rick Green at email@example.com, Nicole BullockFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
GNC Holdings' (GNC) recent joint venture with vitamins and nutritional supplement manufacturer International Vitamin Corporation shows high prospects at present.
We consider this corporate deal in Brazil to be a strategic fit for GNC Holdings (GNC), which currently pulls out all the stops to fortify its global footprint.
U.S. equities look set for a solid open on Wednesday as traders await the release of the latest Federal Reserve meeting minutes. While the economic data remains uneven, President Trump's White House continues to float tax cut ideas as a remedy -- teasing both a capital gains and payroll tax cut. This comes amid worries that a recession could arrive just in time for the 2020 presidential election. Trump took to Twitter this morning to attack the Federal Reserve, yet again, for not cutting rates aggressively enough. The overall message is loud and clear: Both monetary and fiscal stimulus is likely to ramp up.And thus, stocks are starting to perk up. While valuations are still somewhat extended on a historic basis, there are still values to be had. So at times like this, I like to look to lower-priced penny stocks -- or stocks under $10. There are quite a few stocks under $10, so I look to the charts to find ones that look ready for a breakout. * The 10 Best Marijuana Stocks to Buy Now Here are 11 stocks priced under $10 that look ready for a run higher:InvestorPlace - Stock Market News, Stock Advice & Trading Tips GNC (GNC)Shares of supplements and vitamins retailer GNC (NYSE:GNC) are bouncing off of their 50-day moving average in what looks like an emerging rally to its 200-day moving average. Shares have been under massive pressure since peaking in late 2015, losing more than 98% of their value. With expectations so low, the recent announcement of a deal to buy Vitamin Shoppe (NYSE:VSI) for $208 million could result in a relief rally for this penny stock.GNC will next report results on November 8 before the bell. Analysts are looking for earnings of seven cents per share on revenues of $510.1 million. When the company last reported on July 22, earnings of 13 cents beat estimates by a penny on a 13.6% decline in revenues. Smart Sand (SND)Smart Sand (NASDAQ:SND) provides fracking sand and supplies to the energy industry, holding roughly 321 million tons of proven recoverable sand reserves. SNDis somewhat insulated from energy price movements since it's a play on oil and natural gas volumes. And because oil companies must keep pumping out of existing wells when prices fall (to pay fixed costs) profitability has remained intact with a 33% gross margin. * 10 Undervalued Stocks With Breakout Potential Shares look ready for an extension up and out of a three-month consolidation range with a move above its 50-day moving average after the lows set back in December were tested. The company will next report results on November 7 before the bell. Analysts are looking for earnings of 35 cents per share on revenues of $63.1 million. Safe Bulkers (SB)Safe Bulkers (NYSE:SB) provides marine drybulk transportation services out of Greece, helping ship things like coal, grain and iron ore with a fleet of 41 vessels. The company is tied to global trade, which admittedly has been an area of worry amid the standoff between the United States and China. But with Trump increasingly worried about an economic downturn, compromise seems likely.Shares are bouncing off of both their 50-day and 200-day moving averages and look set for a move back to their July high. Such a move would be worth a gain of more than 23% from here. Extraction Oil & Gas (XOG)Shares of independent oil and gas producer Extraction Oil and Gas (NASDAQ:XOG) are once again moving to the upper end of a consolidation range going back to January and look ready for a test above their 200-day moving average that hasn't been tested since the summer of 2018. Coverage of the stock was recently initiated by analysts at KeyBanc Capital Markets with a neutral rating. * Major Headlines Mean Opportunities for Smart Investors The company will next report results on November 5 after the close. Analysts are looking for a loss of nine cents per share on revenues of $238.9 million. When the company last reported on August 1, earnings of 22 cents per share missed estimates by seven cents on a 14.6% decline in revenues. Northern Oil and Gas (NOG)Shares of Northern Oil and Gas (NYSEAMERICAN:NOG) are perking up and over their 50-day moving average and look set for a run towards the 200-day moving average. This caps a downtrend that's been in place since late April, mirroring the pullback in crude oil prices. Management has been using the industry downturn to expand its ground game, buying up acreage at low cost preparing for the inevitable turnaround in energy prices.In the second quarter and third quarter through late July, the company has completed 40 deals snapping up more than 6,000 acres. Deal activity continues to be focused on the Williston Basin in eastern Montana, North Dakota, South Dakota and southern Saskatchewan. AK Steel (AKS)Shares of AK Steel (NYSE:AKS) are holding above their 50-day moving average and look set for another run at their 200-day moving average, continuing a rise off of the late May lows. Because of worries about global manufacturing activity, and thus demand for steel and iron, the stock trades under $10 at an incredibly cheap price-to-earnings multiple of just 4.6x. * 10 Mid-Cap Dividend Stocks to Buy Now The company will next report results on October 24 after the close. Analysts are looking for earnings of six cents per share on revenues of $1.7 billion. When the company last reported on July 29, earnings of 21 cents per share beat estimates by 15 cents on a 3.8% decline in revenues. SRC Energy (SRCI)SRC Energy (NYSEAMERICAN:SRCI) is an independent oil and gas producer based in the Denver basin in Colorado. The company has proved oil and gas reserves of 88 million barrels and 771 billion cubic feet respectively and operates nearly 1,000 wells. Shares are extending off of support from the lows set since December and looks good for a test above its 200-day moving average.The company will next report results on October 24 after the close. Analysts are looking for earnings of six cents per share one revenues of $1.7 billion. When the company last reported on July 29, earnings of 21 cents per share beat estimates by 15 cents on a 3.8% decline in revenues. Comstock Resources (CRK)Shares of Comstock Resources (NYSE:CRK), an independent oil and gas outfit based primarily in Texas, Louisiana and North Dakota, look ready for another run at its 200-day moving average continuing a long sideways channel going back to 2015. Watch for an extension to the $12-a-share level, which would be worth a double from here. * 10 Undervalued Stocks With Breakout Potential The company recently announced the acquisition of Covey Park Energy in a cash and stock transaction valued at roughly $2.2 billion as it expands its footprint in the Haynesville shale area. When analysts at B. Riley FBR initiated coverage back in May, they focused on management's improvement to capital intensity and cost cutting efforts. Prospect Capital Corporation (PSEC)Prospect Capital (NASDAQ:PSEC) is a business development company that specializes in middle market financing, buyouts and recapitalizations of private and micro-cap public companies. It focuses on a variety of industries, from energy to aerospace and consumer services. Shares are testing the upper range of a year-to-date sideways consolidation pattern but look ready for a push back to the early 2017 highs for a move that would be worth a gain of 10% from here.The company will next report results on August 27 after the close. Analysts are looking for earnings of 21 cents per share on revenues of $166.7 million. When the company last reported on May 8, earnings of 21 cents per share beat estimates by a penny on a 5.1% rise in revenues. ASE Technology Holding (ASX)ASE Technology (NYSE:ASX) shares look ready to break up and out of a wedge formation with a push back to levels last seen in the summer of 2018. Such a move would be worth a gain of 10% from here. The company is a provider of semiconductor packaging and testing services -- an industry that is intensely tied to the vagaries of the business cycle since chips are in pretty much every manufactured good. * The 10 Best Marijuana Stocks to Buy Now The company recently reported that July net revenues increased 9% from last year to $1.2 billion. Analysts at Macquarie recently upgraded to buy despite a recent miss of quarterly earnings estimates on better-than-expected revenues. MFA Financial (MFA)MFA Financial (NYSE:MFA) is a diversified REIT focused on residential mortgage assets. Shares have been steadily grinding higher rising along its 200-day moving average as the previous high from late 2017 is challenged. Watch for a breakout here on the expectation of more cheap money easing from the Federal Reserve, which will bolster real estate prices.The company will next report results on November 5 before the bell. Analysts are looking for earnings of 18 cents per share on revenues of $67.8 million. When the company last reported on August 7, earnings of 20 cents per share beat estimates by two cents on a 19.9% rise in revenues.As of this writing, the author held no positions in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Marijuana Stocks to Ride High on the Farm Bill * 8 Biotech Stocks to Watch After the Q2 Earnings Season * 7 Unusual, Growth-Oriented REITs to Buy for Your Portfolio The post 11 Stocks Under $10 to Buy Now appeared first on InvestorPlace.
GNC Holdings Inc. stock has tanked 10.6% in Tuesday trading after the struggling health-and-wellness retailer reported second-quarter sales that missed expectations and said that it will close as many as 900 stores in the coming months. Net income totaled $16.1 million, or 11 cents per share, after net income of $13.3 million, or 16 cents per share, last year. Adjusted EPS was 13 cents, beating the FactSet consensus for 12 cents per share. Sales of $534.0 million was down from $617.9 million last year and below the FactSet guidance for $553.0 million. Domestic same-store sales fell 4.6%, deeper than the 2% FactSet forecast. GNC Chief Executive Kenneth Martindale said deteriorating mall traffic, a trend for the past several year, "accelerated" during the last few quarters. More than a quarter (28%) of GNC stores are in malls while 61% are in strip centers, which he said are "relatively" stable. "We remain on pace to achieve our 2019 and 2020 cost savings targets and the results from our store optimization effort continue to meet our expectations," he said on the call, according to a FactSet transcript. "As a result of the current mall traffic trends, it's likely that we will end up closer to the top end of our original optimization estimate of 700 to 900 store closures." The company is also battling headwinds on Amazon.com Inc. and says it's working closely with the e-commerce giant to drive sales in a "different" marketplace environment. GNC shares fell 25% over the past three months, and more than 48% over the past year. The S&P 500 index is up 6.7% for the past 12 months.
GNC Holdings (NYSE: GNC ) reported second-quarter earnings of 13 cents per share, which beat the analyst consensus estimate of 12 cents by 8.33%. This is a 35% decrease over earnings of 2 cents per share ...
Anyone researching GNC Holdings, Inc. (NYSE:GNC) might want to consider the historical volatility of the share price...
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018. Although hedge funds are not perfect, their consensus picks do deliver solid returns, however. Our data show the top 20 S&P 500 […]
In some ways, all the enthusiasm for CBD oil reminds me of one of my best early trades. Back in 2003, I was walking in New York and people were wearing True Religion jeans everywhere I went. Then I discovered they were paying $200 for them. I bought a pair for myself, and they really were nice. So after my full analysis, I went ahead and bought the stock, too, just as the brand was taking off among the 18- to 34-year-old demographic.True Religion stock was less than a dollar at that time - but when I cashed out, it had run up above $20.Great investing ideas are like that. They're often very simple and right in front of us. They pop up in our daily lives… and we hear about them from friends and neighbors. Just like when everyone stopped renting movies and started getting little red envelopes in their mailbox.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIf you started using Netflix (NASDAQ:NFLX) in the mid-2000s - instead of paying all those late fees to Blockbuster - then congratulations. You uncovered a great business model! Even if you didn't invest in Netflix (or not until much later), you spotted a game-changing company in its very early days.That's what it's all about. Netflix's success is not complicated, just like Facebook (NASDAQ:FB) or Amazon (NASDAQ:AMZN). People have firsthand experience with their products and services, and use them all the time. It's the power of what you know. * 7 Value Stocks to Buy for the Second Half It's Happening Again With CBD OilJust a few months ago, I was in New York again, at one of my favorite little coffee shops. This time everyone had a drink infused with cannabidiol (CBD) oil.A few days later, my girlfriend brought home a CBD lotion. She explained how it was derived from hemp and was an anti-inflammatory, plus it has antioxidant properties, to fight signs of aging and wrinkles. Basically it's the non-psychoactive "cousin" of marijuana - but since it doesn't have tetrahydrocannabinol (THC), it doesn't get you high.I tried CBD, too, and found that it really helps me mellow out to go to sleep. I swear by it. People like Michael J. Fox and Melissa McCarthy use it, too, but it's not just celebrities. If your experience is anything like mine, your friends and loved ones are starting to talk about trying CBD oil as well. People are even using it for their pets!Whether you have tried CBD or not, millions of people have. I think you're going to like the numbers on this one. Here's the latest on the CBD craze: * CBD was a $108 million market in 2014, and by 2022, it'll ring in at $22 billion, according to projections from the Brightfield Group. That's 20,270% growth in just eight years. * Besides the little neighborhood CBD shops that are popping up everywhere, you can also now buy it at CVS and Walgreens. Clearly, CBD products are starting to enter the mainstream. * Sephora and Ulta Beauty (NASDAQ:ULTA) now carry their own CBD products. So does GNC (NYSE:GNC), and Urban Outfitters (NASDAQ:URBN) and Kroger (NYSE:KR) will sell CBD, too. * People with seizure disorders have had great success using CBD to reduce their symptoms. That was how my favorite CBD stock got its start. * A lot of folks are using it to help manage pain, anxiety, depression, and sleep disorders, too. In fact, in one survey from the National Institutes of Health (NIH), about 36% of CBD users found that it was managing their condition "very well by itself." * The implications for CBD fighting the opioid crisis are huge. In a study published in the American Journal of Psychiatry in May, doctors administered CBD to people in recovery from heroin addiction. They found that CBD "significantly reduced both craving and anxiety," with "no significant effects on cognition, and there were no serious adverse effects."The companies providing all this CBD are raking it in - doubling their revenues over the past 12 months. But seeing as hemp-derived CBD just became legal six months ago, there's a lot more to come, especially given the sharp growth trajectory we saw earlier.All from just those little bottles of hemp oil at the drugstore and beauty shop!It reminds me of a famous story I heard on Wall Street. Peter Lynch, a legendary investor, once ran one of the top-performing mutual funds of all time: Fidelity's Magellan fund. Among his biggest winners was Dunkin' Donuts (NASDAQ:DNKN). Apparently he bought it because he liked the coffee - and it ended up being a 10-bagger.Then there's Bill Gates. He once tried fake chicken at a taco truck - it was made out of pea protein, but he couldn't tell the difference from the real thing. His investment in Beyond Meats (NASDAQ:BYND) has paid off handsomely after the company just had one of the best IPOs of the year.That's the "power of what you know."And now I think CBD could be your "power of what you know" moment. CBD Early Investor's KitNow is the time to invest while the stocks are still small. And small companies are the job creators. The innovators. Invest in a high-quality business model in its early days - and once it takes off… that's how fortunes are made.I believe in this opportunity, so this week I'll be sharing a series of articles to help you truly "know" about it.I've also been working with my publisher to put together a complete CBD Early Investor's Kit. We've got enough for the first 4,000 respondents, and here's what you get: * The 1 CBD Stock in the World. One little company has been eating up much of the U.S. market share in CBD, because it can produce a higher-quality product - and lots of it. I've got a whole investment guide to fill you in before the crowd catches on. * Three More CBD Stocks to Fatten Your Wallet. These other CBD stocks are quietly doubling revenues, tempting away top executives from household brands, and striking sweet deals on new product lines. You'll see their names, ticker symbols, and buy-under prices in my full report. * Plus, to help you really get to know the product, you'll also get a 15-day supply of high-grade CBD from CannaComplete. If you're like me, you like to see what all the fuss is about firsthand. That's why, on my recent trip, I went to the "Starbucks of China." I wasn't impressed with that but I do understand the CBD craze, now that I've taken part. There's a lot of weird rumors about CBD, from haters and fanatics. Now you can see the real deal for yourself.Those of us who have tried CBD know that its appeal is simple and straightforward. Just like with Netflix and Facebook - or with True Religion, back in the day - that's what makes it powerful.As investors, there are plenty of avenues we can take to cash in on the CBD craze. Click here for more details and to claim one of these research packages now.Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you're interested in making triple-digit gains from the world's biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments strategy today. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Value Stocks to Buy for the Second Half * 7 Hot Stocks to Buy for a Seemingly Sleepy Summer * 6 Chip Stocks Staring At Big Headwinds in 2019 Compare Brokers The post CBD Oil: The True Power of a Consumer Craze appeared first on InvestorPlace.
To take a flyer or not to take a flyer on GNC Holdings (GNC)? On the other, free cash flow is still 6x greater than capital spending at $120 million, and GNC's stores are still generating over $564 million in quarterly sales, with the April earnings announcement reporting a slight rise in Ebita to $65.9 million. Warning! GuruFocus has detected 3 Warning Signs with GNC.
Despite year-over-year decline in earnings and revenues, better performing International segment and key developments favor GNC Holdings (GNC) in Q1.